Management Strategies in Sarcoidosis: Why Short-Term Prednisone Monotherapy Is Simply Not Enough

Despite therapeutic protocols increasingly being composed of multiple agents, it is not all that uncommon for individuals with sarcoidosis to present to sarcoid specialty clinics only on a 2-3 week prednisone course for treatment and not show any resolution of their signs and symptoms. In order to understand why the response in inadequate, we will need to delve deeper into the immunological cascade for this disease process.